Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EasyPoint Blood Collection Plus

K-Number: K202325 · 2021-04-09

ApplicantRetractable Technologies, Inc.
Decision Date2021-04-09
Product CodeJKA
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

EasyPoint Blood Collection Plus is a medical device manufactured by Retractable Technologies, Inc.. It received FDA 510(k) clearance on 2021-04-09 under approval number K202325. The device is classified under product code JKA. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EasyPoint Blood Collection Plus?

EasyPoint Blood Collection Plus is a medical device that received FDA 510(k) clearance on 2021-04-09. It is manufactured by Retractable Technologies, Inc.. The 510(k) number is K202325.

When was EasyPoint Blood Collection Plus approved by the FDA?

EasyPoint Blood Collection Plus received FDA 510(k) clearance on 2021-04-09, under approval number K202325.

What company makes EasyPoint Blood Collection Plus?

EasyPoint Blood Collection Plus is manufactured by Retractable Technologies, Inc..

What is the FDA product code for EasyPoint Blood Collection Plus?

The FDA product code for EasyPoint Blood Collection Plus is JKA.

Related Clinical Trials

NCT01174108 Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells RECRUITING NCT06915012 Impact of Biophoton Therapy on Chronic Severe Arthritis Pain RECRUITING NCT07595068 Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases NOT_YET_RECRUITING NCT07587294 Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction NOT_YET_RECRUITING NCT06968845 A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis RECRUITING NCT07573059 Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients RECRUITING

Related Devices (Code: JKA)

K162233Kurin Blood Culture Collection SetPathway, LLC K160657BD Vacutainer Barricor Lithium Heparin Plasma Blood Collection TubeBecton, Dickinson and Company K153309BD Vacutainer UltraTouch Push Button Blood Collection SetBecton, Dickinson and Company K152924TIVA¿Velano Vascular K163073Sol-Care Safety Blood Collection Needle with and without Pre-Attached HolderSol-Millennium Medical, Inc. K163508PIVOVelano Vascular

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑